Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carina Hasenoehrl, Martin Storr & Rudolf Schicho. (2017) Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?. Expert Review of Gastroenterology & Hepatology 11:4, pages 329-337.
Read now
Read now
Articles from other publishers (14)
Mohammad Bashashati, Emma Leishman, Heather Bradshaw, Solmaz Sigaroodi, Eric Tatro, Tamis Bright, Richard McCallum & Irene Sarosiek. (2020) Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex‐ and subtype‐dependent observation. Neurogastroenterology & Motility 33:1.
Crossref
Crossref
Andrea Verdugo-Meza, Jiayu Ye, Hansika Dadlani, Sanjoy Ghosh & Deanna L. Gibson. (2020) Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 12:5, pages 1434.
Crossref
Crossref
Samiksha Pandey, Saima Kashif, Mina Youssef, Somia Sarwal, Hala Zraik, Ripudaman Singh & Ian H. Rutkofsky. (2020) Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy. Complementary Therapies in Medicine 48, pages 102242.
Crossref
Crossref
Richard W. McCallum & Mohammad Bashashati. (2019) Cannabis for Gastroparesis: Hype or Hope?. American Journal of Gastroenterology 114:6, pages 865-866.
Crossref
Crossref
Magdalena Grill, Carina Hasenoehrl, Melanie Kienzl, Julia Kargl & Rudolf Schicho. (2018) Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. Histochemistry and Cell Biology 151:1, pages 5-20.
Crossref
Crossref
Marcella Pesce, Alessandra D'Alessandro, Osvaldo Borrelli, Stefano Gigli, Luisa Seguella, Rosario Cuomo, Giuseppe Esposito & Giovanni Sarnelli. (2017) Endocannabinoid-related compounds in gastrointestinal diseases. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
Rudolf Schicho. 2017. Mechanisms of Molecular Carcinogenesis – Volume 1. Mechanisms of Molecular Carcinogenesis – Volume 1
1
10
.
C. Hasenoehrl, U. Taschler, M. Storr & R. Schicho. (2016) The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterology & Motility 28:12, pages 1765-1780.
Crossref
Crossref
Zachary Wilmer Reichenbach & Ron Schey. (2016) Cannabinoids and GI Disorders: Endogenous and Exogenous. Current Treatment Options in Gastroenterology 14:4, pages 461-477.
Crossref
Crossref
M. S. Volz, B. Siegmund & W. Häuser. (2016) Wirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden in der GastroenterologieEfficacy, tolerability, and safety of cannabinoids in gastroenterology. Der Schmerz 30:1, pages 37-46.
Crossref
Crossref
Angelo A. Izzo, Giulio G. Muccioli, Michael R. Ruggieri & Rudolf Schicho. 2015. Endocannabinoids. Endocannabinoids
423
447
.
Andrei Sibaev, Birol Yuece, Hans Dieter Allescher, Dieter Saur, Martin Storr & Manfred Kurjak. (2014) The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats. Pharmacological Reports 66:2, pages 256-263.
Crossref
Crossref
Kun Li, Jakub Fichna, Rudolf Schicho, Dieter Saur, Mohammad Bashashati, Ken Mackie, Yongyu Li, Andreas Zimmer, Burkhard Göke, Keith A. Sharkey & Martin Storr. (2013) A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology 71, pages 255-263.
Crossref
Crossref
Angelo A Izzo, Raffaele Capasso, Gabriella Aviello, Francesca Borrelli, Barbara Romano, Fabiana Piscitelli, Laura Gallo, Francesco Capasso, Pierangelo Orlando & Vincenzo Di Marzo. (2012) Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. British Journal of Pharmacology 166:4, pages 1444-1460.
Crossref
Crossref